S
32.91
0.15 (0.46%)
| Penutupan Terdahulu | 32.76 |
| Buka | 33.00 |
| Jumlah Dagangan | 1,307,834 |
| Purata Dagangan (3B) | 1,172,303 |
| Modal Pasaran | 3,121,849,088 |
| Harga / Jualan (P/S) | 13.14 |
| Harga / Buku (P/B) | 9.12 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 5 May 2025 - 9 May 2025 |
| EPS Cair (TTM) | -2.55 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 20.22% |
| Nisbah Semasa (MRQ) | 10.25 |
| Aliran Tunai Operasi (OCF TTM) | -229.84 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -134.32 M |
| Pulangan Atas Aset (ROA TTM) | -50.15% |
| Pulangan Atas Ekuiti (ROE TTM) | -106.71% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menurun | Menurun |
| Biotechnology (Global) | Menurun | Menurun | |
| Stok | Scholar Rock Holding Corporatio | Bercampur | Menaik |
AISkor Stockmoo
-0.4
| Konsensus Penganalisis | -2.0 |
| Aktiviti Orang Dalam | 1.5 |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -3.5 |
| Purata | -0.40 |
|
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 4.34% |
| % Dimiliki oleh Institusi | 118.82% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| AKKARAJU SRINIVAS | 30.46 | - | 7,632 | 232,471 |
| BRUDNICK RICHARD | 30.46 | - | 7,632 | 232,471 |
| BUROW KRISTINA | 30.46 | - | 7,632 | 232,471 |
| FLIER JEFFREY S. | 30.46 | - | 7,632 | 232,471 |
| GILMAN MICHAEL | 30.46 | - | 7,632 | 232,471 |
| PENG KATIE | 30.46 | - | 7,632 | 232,471 |
| REED JOSHUA | 30.46 | - | 7,632 | 232,471 |
| Jumlah Keseluruhan Kuantiti Bersih | 53,424 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 1,627,295 | |||
| Purata Pembelian Keseluruhan ($) | 30.46 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| FLIER JEFFREY S. | Pengarah | 22 May 2025 | Diperolehi (+) | 7,632 | 30.46 | 232,471 |
| GILMAN MICHAEL | Pengarah | 22 May 2025 | Diperolehi (+) | 7,632 | 30.46 | 232,471 |
| PENG KATIE | Pengarah | 22 May 2025 | Diperolehi (+) | 7,632 | 30.46 | 232,471 |
| AKKARAJU SRINIVAS | Pengarah | 22 May 2025 | Diperolehi (+) | 7,632 | 30.46 | 232,471 |
| BUROW KRISTINA | Pengarah | 22 May 2025 | Diperolehi (+) | 7,632 | 30.46 | 232,471 |
| REED JOSHUA | Pengarah | 22 May 2025 | Diperolehi (+) | 7,632 | 30.46 | 232,471 |
| BRUDNICK RICHARD | Pengarah | 22 May 2025 | Diperolehi (+) | 7,632 | 30.46 | 232,471 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |